Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › CRISPR/Cas9-based repressors for silencing gene targets in vivo and methods of use

CRISPR/Cas9-based repressors for silencing gene targets in vivo and methods of use

US Patent 12428631 · Granted Sep 30, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Genome engineering with CRISPR-Cas systems in eukaryotes2025
Therapeutic targets for the correction of the human dystrophin gene by gene edit2025
Therapeutic applications of CPF1-based genome editing2025
Compositions and methods for the induction and tuning of gene expression2025
Compositions and methods for epigenome editing2025
Genetic correction of mutated genes2024
Genome engineering with Type I CRISPR systems in eukaryotic cells2024
Compositions and methods of improving specificity in genomic engineering using R2022
Genome engineering with type I CRISPR systems in eukaryotic cells2022
Methods and compositions for multiplexing single cell and single nuclei sequenci2022
Compositions, systems and methods for cell therapy2022
Compositions and methods for epigenome editing2021